Other Income / (Expense)

3 Months Ended

Sep. 30, 2022

Note 11. Other Income / (Expense):

The components of other income (expense) in the accompanying Statement of Earnings and Comprehensive Income are as follows:


	Quarter Ended
	September 30,
	2022		2021
Interest expense	$	(3,790)	$	(3,409)
Interest income		433		193
Other non-operating income (expense), net⁽¹⁾		50,756		7,377
Total other income (expense)	$	47,399	$	4,161

⁽¹⁾	Primarily due to a $37.2 million gain on the sale of our ChemoCentryx investment and a $11.7 million gain on the sale of Eminence.